Analyst Research
| Report Title | Price |
|---|---|
|
Provider: Stock Traders Daily
|
$58.00
|
|
Provider: Pechala's Reports
|
$10.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
ArthroCare Corporation Issues FY 2012 Revenue Guidance Below Analysts' Estimates-Conference Call
ArthroCare Corporation announced that for fiscal 2012, it expects low single digit revenue growth. The Company reported revenues of $355 million in fiscal 2011. According to I/B/E/S Estimates, analysts were expecting the Company to report revenues of $377 million.
Latest Developments for ArthroCare Corp
- ArthroCare Corporation Updates FY 2011 Revenue Guidance To A Range In Line With Analysts' Estimates-Conference Call
- ArthroCare Corporation Receives FDA Clearance for SpeedLock Knotless Fixation Device
- ArthroCare Corporation Lowers FY 2011 Revenue Guidance-Conference Call
- ArthroCare Corporation Receives FDA Clearance for SpeedFix Suture System
- Share this
- Link this
- Digg this


Follow Reuters